Luo, Dingyuan <br/><br/>
Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.  [electronic resource] 

 -  Carcinogenesis  12 2019 
 - 1480-1491 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1460-2180 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgz069  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Brain Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Female<br/>Glioblastoma--metabolism<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Organophosphates--pharmacology<br/>Phosphorylation--drug effects<br/>STAT3 Transcription Factor--drug effects<br/>Valproic Acid--analogs & derivatives<br/>Xenograft Model Antitumor Assays